{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:34:42Z","timestamp":1779197682381,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014332","name":"Life Sciences Research Network Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015846","name":"Welsh Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118543","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:54:54Z","timestamp":1767113694000},"page":"118543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Coumarin-stavudine (d4T) novel hybrid ProTides with dual-functionality and enhanced anti-HIV activity"],"prefix":"10.1016","volume":"304","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1806-9623","authenticated-orcid":false,"given":"Sahar B.","family":"Kandil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Westwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118543_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00883-20","article-title":"Identification of an antiretroviral small molecule that appears to be a host-targeting inhibitor of HIV-1 assembly","volume":"95","author":"Reed","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2025.118543_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115741","article-title":"Nucleoside-based anticancer drugs: mechanism of action and drug resistance","volume":"215","author":"Hruba","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118543_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116614","article-title":"Lipid-conjugated nucleoside monophosphate and monophosphonate prodrugs: a versatile drug delivery paradigm","volume":"275","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib5","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.1021\/acs.jmedchem.4c00899","article-title":"Discovery of GS-7682, a novel 4'-cyano-modified C-nucleoside prodrug with broad activity against pneumo- and picornaviruses and efficacy in RSV-infected African green monkeys","volume":"67","author":"Siegel","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","article-title":"The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold","volume":"154","author":"Seley-Radtke","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.118543_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/jm00060a013","article-title":"Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT","volume":"36","author":"McGuigan","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/acsbiomedchemau.4c00071","article-title":"Synthesis and modification of cordycepin-phosphoramidate ProTide derivatives for antiviral activity and metabolic stability","volume":"5","author":"Thiraporn","year":"2024","journal-title":"ACS Bio. Med. Chem. Au."},{"key":"10.1016\/j.ejmech.2025.118543_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108293","article-title":"Design, synthesis, and anti-cancer evaluation of the novel conjugate of gemcitabine's ProTide prodrug based on CD13","volume":"157","author":"Zhang","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172747","article-title":"Selected nucleos(t)ide-based prescribed drugs and their multi-target activity","volume":"865","author":"Pastuch-Gawo\u0142ek","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118543_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/128_2014_561","article-title":"Prodrugs of phosphonates and phosphates: crossing the membrane barrier","volume":"360","author":"Wiemer","year":"2015","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib12","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a \u03b2-d-2'-deoxy-2'-\u03b1-fluoro-2'-\u03b2-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib13","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1128\/AAC.00128-15","article-title":"Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for hepatitis B virus therapy","volume":"59","author":"Murakami","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118543_bib14","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3390\/pharmaceutics13101656","article-title":"Activation of tenofovir alafenamide and sofosbuvir in the human lung and its implications in the development of nucleoside\/nucleotide prodrugs for treating SARS-CoV-2 pulmonary infection","volume":"13","author":"Li","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.118543_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-024-03010-1","article-title":"A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)","volume":"43","author":"Spiliopoulou","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118543_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126721","article-title":"Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity","volume":"29","author":"Kandil","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.01335-10","article-title":"INX-08189, a phosphoramidate prodrug of 6-O-methyl-2'-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties","volume":"55","author":"Vernachio","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118543_bib18","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1016\/j.bmcl.2016.10.077","article-title":"ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolites","volume":"26","author":"Kandil","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib19","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1016\/S0021-9258(19)39299-3","article-title":"Synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides","volume":"265","author":"Hostetler","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/anie.199600701","article-title":"2-Nucleos-5\u2019-O-yl-4H-1,2,3-benzodioxaphosphinin-2-oxides \u2013 a new concept for lipophilic, potential prodrugs of biologically active nucleoside monophosphates","volume":"35","author":"Meier","year":"1996","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118543_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/acsmedchemlett.1c00624","article-title":"Phosphoramidate prodrugs continue to deliver: the journey of remdesivir (GS-5734) from RSV to SARS-CoV-2","volume":"13","author":"Mackman","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2013.09.047","article-title":"Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides","volume":"70","author":"McGuigan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib23","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1021\/jm2011673","article-title":"Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents","volume":"54","author":"McGuigan","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib24","first-page":"1","article-title":"Low dose versus high dose stavudine for treating people with HIV infection","volume":"28","author":"Magula","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2025.118543_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/13543784.2012.664635","article-title":"Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV\/AIDS","volume":"21","author":"Uckun","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2025.118543_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/14728222.2020.1724961","article-title":"Chemopreventive efficacy of stampidine in a murine breast cancer model","volume":"24","author":"Sahin","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2025.118543_bib27","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/molecules28052413","article-title":"Therapeutic effects of coumarins with different substitution patterns","volume":"28","author":"Flores-Morales","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118543_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2024.100202","article-title":"Coumarin: a natural solution for alleviating inflammatory disorders","volume":"7","author":"Saadati","year":"2024","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118543_bib29","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.bmcl.2016.02.088","article-title":"7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer","volume":"26","author":"Kandil","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejmech.2016.07.056","article-title":"Therapeutic potential of coumarins as antiviral agents","volume":"123","author":"Hassan","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03217","article-title":"Coumarin: an emerging antiviral agent","volume":"6","author":"Mishra","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.118543_bib32","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/ph16111538","article-title":"Recent progress in synthesis, POM analyses and SAR of coumarin-hybrids as potential anti-HIV agents \u2013 a mini review","volume":"16","author":"Suleiman","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118543_bib33","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.bmc.2007.11.045","article-title":"Activity of Mannich bases of 7-hydroxycoumarin against Flaviviridae","volume":"16","author":"Mazzei","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028923","article-title":"Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays","volume":"6","author":"Pohjala","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118543_bib35","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/jm00093a004","article-title":"The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum","volume":"35","author":"Kashman","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib36","first-page":"155","article-title":"Calanolides, the naturally occurring anti-HIV agents","volume":"3","author":"Xu","year":"2000","journal-title":"Curr. Opin. Drug Discov. Dev"},{"key":"10.1016\/j.ejmech.2025.118543_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106918","article-title":"4-Phenylcoumarin derivatives as new HIV-1 NNRTIs: design, synthesis, biological activities, and computational studies","volume":"141","author":"Batran","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib38","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.3390\/ijms24032839","article-title":"Plant coumarins with anti-HIV activity: isolation and mechanisms of action","volume":"24","author":"Sharapov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118543_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104863","article-title":"Coumarin-based derivatives with potential anti-HIV activity","volume":"150","author":"Xu","year":"2021","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2025.118543_bib40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1039\/D2MD00438K","article-title":"Visible and NIR light photoactivatable o-hydroxycinnamate system for efficient drug release with fluorescence monitoring","volume":"14","author":"Gupta","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib41","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1021\/acs.chemrev.9b00145","article-title":"Coumarin-based small-molecule fluorescent chemosensors","volume":"119","author":"Cao","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118543_bib42","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1021\/acsabm.4c00595","article-title":"Syntheses and applications of coumarin-derived fluorescent probes for real-time monitoring of NAD(P)H dynamics in living cells across diverse chemical environments","volume":"7","author":"Olowolagba","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ejmech.2025.118543_bib43","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1590\/S0103-50532010000800011","article-title":"Esterase screening using whole cells of Brazilian soil microorganisms","volume":"21","author":"Mantovani","year":"2010","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118543_bib44","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/ijms24032129","article-title":"4-Methylumbelliferone targets revealed by public data analysis and liver transcriptome sequencing","volume":"24","author":"Tsitrina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118543_bib45","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1134\/S1068162024050108","article-title":"Synthesis and importance of coumarin derivatives in medicinal chemistry: a comprehensive review","volume":"50","author":"Samanth","year":"2024","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fimmu.2015.00123","article-title":"4-Methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer","volume":"6","author":"Nagy","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118543_bib47","first-page":"263","article-title":"Effect of 4-methylumbelliferone on cell-free synthesis of hyaluronic acid","volume":"43","author":"Nakamura","year":"1997","journal-title":"Biochem. Mol. Biol. Int."},{"key":"10.1016\/j.ejmech.2025.118543_bib48","article-title":"The pharmacokinetics and pharmacodynamics of 4-methylumbelliferone and its glucuronide metabolite in mice","volume":"vol. 14","author":"Nagy","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118543_bib49","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41385-021-00409-3","article-title":"Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection","volume":"14","author":"Egedal","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ejmech.2025.118543_bib51","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/1570162X14666161003152458","article-title":"Reactivation of latent HIV-1 in latently infected cells by coumarin compounds: hymecromone and scoparone","volume":"14","author":"Li","year":"2016","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ejmech.2025.118543_bib52","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00044-023-03094-y","article-title":"Future challenges and opportunities with fluorine in drugs?","volume":"32","author":"O'Hagan","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118543_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejmech.2015.12.037","article-title":"Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells","volume":"110","author":"Kandil","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib54","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/1535-7163.MCT-18-0037","article-title":"Novel trifluoromethylated enobosarm analogues with potent antiandrogenic activity in vitro and tissue selectivity in vivo","volume":"17","author":"Dart","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.118543_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/molecules26010056","article-title":"Synthesis and biological evaluation of bicalutamide analogues for the potential treatment of prostate cancer","volume":"26","author":"Kandil","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118543_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127817","article-title":"Synthesis, biological evaluation and X-ray analysis of bicalutamide sulfoxide analogues for the potential treatment of prostate cancer","volume":"36","author":"Kandil","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/ml400398t","article-title":"Multicolor imaging of endoplasmic reticulum-located esterase as a prodrug activation enzyme","volume":"5","author":"Hakamata","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib58","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1039\/D3MD00055A","article-title":"Biological evaluation of novel amidino substituted coumarin-benzazole hybrids as promising therapeutic agents","volume":"14","author":"Be\u010d","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/157016206777709393","article-title":"Coumarins as inhibitors of HIV reverse transcriptase","volume":"4","author":"Kostova","year":"2006","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ejmech.2025.118543_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1570163814666170531115452","article-title":"Quinoline, coumarin and other heterocyclic analogs based HIV-1 integrase inhibitors","volume":"15","author":"Wadhwa","year":"2018","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.ejmech.2025.118543_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115987","article-title":"Is it still worth renewing nucleoside anticancer drugs nowadays?","volume":"264","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4081\/idr.2013.s1.e5","article-title":"HIV drug resistance: problems and perspectives","volume":"6","author":"Pennings","year":"2013","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.ejmech.2025.118543_bib63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/d41573-025-00165-0","article-title":"FDA approves twice-yearly capsid inhibitor for HIV prevention","volume":"24","author":"Mullard","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118543_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fphar.2013.00028","article-title":"Mechanisms and insights into drug resistance in cancer","volume":"4","author":"Zahreddine","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118543_bib65","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1021\/jm401853a","article-title":"Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development","volume":"57","author":"Slusarczyk","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib66","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1128\/AAC.46.11.3613-3616.2002","article-title":"Stampidine is a potent inhibitor of zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations","volume":"46","author":"Uckun","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118543_bib67","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s43440-023-00501-4","article-title":"Polypharmacology: promises and new drugs in 2022","volume":"75","author":"Ryszkiewicz","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2025.118543_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106055","article-title":"Polypharmacology: the science of multi-targeting molecules","volume":"176","author":"Kabir","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118543_bib69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/17460441.2024.2322990","article-title":"Molecular hybridization: a powerful tool for multitarget drug discovery","volume":"19","author":"de Sena Murteira Pinheiro","year":"2024","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118543_bib70","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/cr5002035","article-title":"Synthesis of nucleoside phosphate and phosphonate prodrugs","volume":"114","author":"Pradere","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118543_bib71a","article-title":"Phenol","year":"2014","journal-title":"TOXBASE\u00ae"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118543_bib71b","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0006-2952(84)90305-8","article-title":"Mechanisms of toxic injury to isolated hepatocytes by 1-naphthol","volume":"33","author":"Doherty","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118543_bib71c","series-title":"StatPearls [Internet]","article-title":"Phenol Toxicity","author":"owns","year":"2025"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118543_bib72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2025.01.040","article-title":"A phase III randomized study of first-line NUC-1031\/cisplatin vs. gemcitabine\/cisplatin in advanced biliary tract cancer","volume":"83","author":"Knox","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.118543_bib73","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1016\/j.bmc.2014.05.032","article-title":"Coumarin hybrids as novel therapeutic agents","volume":"22","author":"Sandhu","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib74","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejmech.2015.08.033","article-title":"Current developments of coumarin-based anti-cancer agents in medicinal chemistry","volume":"102","author":"Emami","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib75","doi-asserted-by":"crossref","first-page":"16556","DOI":"10.1002\/chem.201302037","article-title":"4-Trifluoromethyl-substituted coumarins with large Stokes shifts: synthesis, bioconjugates, and their use in super-resolution fluorescence microscopy","volume":"19","author":"Schill","year":"2013","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2025.118543_bib76","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tetlet.2014.07.014","article-title":"Efficient synthesis of terminal 4-methylumbelliferyl labeled 5-fluoro-2\u2032-deoxyuridine-5\u2032-O-tetraphosphate (Um-PPPP-FdU): a potential probe for homogenous fluorescent assay","volume":"55","author":"Kore","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-3542(97)00029-6","article-title":"Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variation","volume":"35","author":"McGuigan","year":"1997","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.118543_bib78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0166-3542(91)90071-X","article-title":"Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3\u2019-azido-3\u2019-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound","volume":"15","author":"McGuigan","year":"1991","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.118543_bib79","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.1021\/jo201492m","article-title":"Synthesis of diastereomerically pure nucleotide phosphoramidates","volume":"76","author":"Ross","year":"2011","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib80","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1021\/acs.orglett.7b00469","article-title":"Mechanism-based solution to the ProTide synthesis problem: selective access to sofosbuvir, acelarin, and INX-08189","volume":"19","author":"Simmons","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib81","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nprot.2007.517","article-title":"Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later","volume":"3","author":"Pannecouque","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2025.118543_bib82","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.apsb.2019.08.013","article-title":"Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118543_bib83","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/acs.jmedchem.0c01747","article-title":"Tenofovir-amino acid conjugates act as polymerase substrates \u2013 implications for avoiding cellular phosphorylation in the discovery of nucleotide analogues","volume":"64","author":"Gu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib84","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1021\/acs.biochem.4c00176","article-title":"Regiochemical analysis of the ProTide activation mechanism","volume":"63","author":"Glockzin","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118543_bib85","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1021\/jm9807104","article-title":"Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR","volume":"42","author":"Siddiqui","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118543_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126897","article-title":"Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents?","volume":"30","author":"Proch\u00e1zkov\u00e1","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118543_bib87","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/17460441.2020.1798926","article-title":"Open access in silico tools to predict the ADMET profiling of drug candidates","volume":"15","author":"Kar","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118543_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501308X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501308X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:49:34Z","timestamp":1771465774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342501308X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":88,"alternative-id":["S022352342501308X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118543","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coumarin-stavudine (d4T) novel hybrid ProTides with dual-functionality and enhanced anti-HIV activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118543"}}